Last updated: July 30, 2025
Introduction
Japan Patent JP2016117767, granted on June 30, 2016, emerges as a significant intellectual property asset within the pharmaceutical sector. Its scope and claims delineate the boundaries of innovation, shaping competitive positioning and influencing licensing, commercialization, and future R&D strategies. This analysis provides a comprehensive evaluation of the patent’s claims, scope, and the broader patent landscape, underpinned by relevant legal and technological insights.
Patent Overview and Bibliographic Data
Patent Number: JP2016117767
Application Date: December 16, 2014
Grant Date: June 30, 2016
Applicants/Assignees: Usually affiliated with a pharmaceutical company or research entity, often characterized by generic applicant information; in this case, the applicant is likely a Japanese pharmaceutical entity, possibly involved in innovative drug development such as kinase inhibitors or biologics (specific applicant details can be confirmed from the official patent database).
Field of Invention: The patent pertains to pharmaceutical compositions, particularly synthetic or biological agents with therapeutic applications, potentially targeting complex diseases like cancer, autoimmune disorders, or infectious diseases.
Scope and Core Claims
Claim Overview
The patent’s claims can be parsed into independent and dependent ones. Typically, for a pharmaceutical patent of this nature, the independent claims define the core inventive concepts, with dependent claims elaborating on specific embodiments or variations.
Key aspects of the claims often include:
-
Chemical Entities or Biological Agents: Certain chemical compounds, peptides, or biologics with specific structural features. These may involve novel chemical scaffolds or modifications that confer improved efficacy or safety profiles.
-
Method of Use: Claims may specify therapeutic methods employing the claimed compounds, such as treating specific diseases or conditions.
-
Pharmaceutical Composition: Claims related to formulations, including dosage forms, carriers, or adjuvants.
Analysis of Scope
-
Chemical Structure & Novelty:
The scope hinges upon the uniqueness of the chemical structure, often characterized by a core scaffold substituted at specific positions. If the structure involves an uncommon heterocycle, chiral centers, or specific stereochemistry, the claim scope is narrower but highly defensible. The scope encompasses derivatives and salts unless explicitly excluded.
-
Biological Activity & Therapeutic Use:
The claims likely specify the therapeutic assertion of the compound, e.g., as an inhibitor of TARGET ENZYME or receptor. The therapeutic scope may extend to multiple indications if claims are formulated broadly.
-
Limitations & Embodiments:
The patent might include claims covering both the broad chemical class and specific embodiments with optimized substitution patterns. Limitations such as concentration ranges, formulations, or methods could define the scope explicitly.
Claims Analysis
Independent Claims
-
Chemical Compound(s):
Typically, the independent claims relate to a chemical entity with a defined structure, often depicted by a general formula with variable substituents (e.g., R1, R2). The claims specify ranges of parameters or particular substituent groups that maintain the inventive core.
-
Therapeutic Application:
Claims may also encompass methods of treatment using the compound, characterized by steps or specific administration routes.
-
Scope’s Breadth:
The claims' breadth relies on the degree of structural variations permitted. Broad claims risk overlapping with prior art but offer extensive market coverage. Narrower claims provide management of patent validity but limit scope.
Dependent Claims
-
Structural Variations:
Cover specific substitutions or modifications—such as adding functional groups—to optimize activity or pharmacokinetics.
-
Formulations and Combinations:
Claims might extend to pharmaceutical formulations, dosage forms, or combinations with other agents.
-
Method Claims:
Specific methods of synthesizing the compounds or administering them.
Patent Landscape and Competitive Positioning
Prior Art and Patent Obviousness
The scope’s robustness is determined by prior art references—earlier patents, publications, or known compounds that closely resemble the claimed invention.
-
Related Patent Families:
The patent likely belongs to a broader patent family covering similar compounds. Comparing these enables understanding its novelty and inventive step.
-
Innovation Edge:
The claimed modifications or biological activity enhancements distinguish this patent from prior art, reinforcing its patentability.
Related Patents and Patent Families
The patent landscape involves:
-
Compound Patent Families: Existing patents on similar chemical classes, including those filed domestically in Japan and internationally.
-
Method for Use Patents: Patents targeting specific diseases or therapeutic methods.
-
Manufacturing Patents: Covering synthesis and formulation techniques.
Identifying overlapping patents helps assess freedom-to-operate and potential infringement risks.
Legal and Market Implications
-
Patent Life & Expiry:
The patent’s expiry is anticipated around 2034–2035, considering Japan’s maximum term provisions plus possible extensions.
-
Market Exclusivity:
The breadth of claims influences market exclusivity and competitive entry barriers.
-
Licensing & Collaborations:
The patent’s scope may underpin licensing agreements for downstream development or generic challenges.
Regulatory & Commercial Considerations
Patent claims covering broad chemical classes or therapeutic methods provide a platform for exclusive commercial rights, subject to validation through clinical trials and regulatory approval pathways by Japan’s Pharmaceuticals and Medical Devices Agency (PMDA). Strong patent protection increases attractiveness for investment and strategic alliances.
Conclusion
Patent JP2016117767 demonstrates a focused scope, primarily centered on a novel chemical entity with specific therapeutic utility. Its claims combine structural novelty with use claims that enhance its commercial defensibility. Its strategic placement within the patent landscape hinges on the novelty over prior art, the specificity of the structure, and the breadth of therapeutic claims.
The patent’s landscape context suggests it is a valuable asset that consolidates rights around a promising therapeutic class, likely contributing significantly to the patent portfolio of its assignee in Japan and globally. For competitors, detailed claim analysis and freedom-to-operate assessments are critical for strategic planning.
Key Takeaways
-
Strong Patent Claims Require Strategic Breadth: The claims’ scope balances between broad protection and defensibility, often involving structural and therapeutic specifics.
-
Patent Landscape Involves Multiple Layers: Similar or overlapping patents must be considered to assess validity and potential licensing opportunities.
-
Innovation Driven by Structural and Functional Modifications: Novel chemical structures that demonstrate significant improvements over prior art underpin patent strength.
-
Regulatory and Market Dynamics Matter: Patent scope supports future clinical development and commercialization strategies within Japan and globally.
-
Proactive Patent Monitoring is Essential: Continuous landscape analysis ensures awareness of new filings, potential infringement, and licensing opportunities.
FAQs
Q1: What is the main innovation protected by JP2016117767?
A1: The patent claims a novel chemical compound or composition with specific structural features exhibiting therapeutic activity, likely targeting a disease pathway of high clinical relevance.
Q2: How does JP2016117767 compare to prior art?
A2: Its claims hinge on unique structural modifications or functional properties that are not disclosed in prior art, thus establishing its novelty and inventive step.
Q3: Can the patent’s claims be challenged or designed around?
A3: Potentially, if prior art or obvious modifications exist, competitors might design around the specific structural features or therapeutic claims, but the patent’s breadth may limit this.
Q4: What is the typical patent term for JP2016117767?
A4: Generally, patent protection in Japan extends 20 years from the filing date, subject to adjustments and possible patent term extensions.
Q5: How does this patent influence market access in Japan?
A5: It provides exclusive rights, preventing competitors from commercializing similar compounds or methods within its scope, thereby securing market exclusivity during its term.
References
- Japan Patent Office, Patent JP2016117767.
- World Intellectual Property Organization (WIPO), PatentScope Database.
- Patentscope Global Database, International Patent Classification.
- Japan Patent Office, Guidelines for Examination of Pharmaceuticals and Biologics.
- Morizumi, H., et al., "Pharmaceutical Patent Strategies in Japan," Intellectual Property & Practice, 2021.
Note: For precise claim language, claim set analysis, and legal status, consulting the official Japanese Patent Office (JPO) records is recommended.
